Except for antipsychotic effects, no longitudinal data has suggested if increased CRP levels were associated with poor prognosis and outcomes in schizophrenia (including hospitalizations, accelerated cognitive impairment and functioning). This evidence concerns the gene CRP and schizophrenia.